Vanda Pharmaceuticals, Inc. (VNDA) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.38 --0%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Trustar Bank to acquire Forbright Bank branches for $750M in deposits
- Wolfe Research sees strong S&P 500 earnings momentum
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
